{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:43:06Z","timestamp":1791474186599,"version":"4.3.4"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019534","name":"Science Fund for Distinguished Young Scholars of Guangxi Province","doi-asserted-by":"publisher","award":["2020B1515020026"],"award-info":[{"award-number":["2020B1515020026"]}],"id":[{"id":"10.13039\/501100019534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202103000089"],"award-info":[{"award-number":["202103000089"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142275","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:36:30Z","timestamp":1742301390000},"page":"142275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P4","title":["Mechanism of liver x receptor alpha in intestine, liver and adipose tissues in metabolic associated fatty liver disease"],"prefix":"10.1016","volume":"307","author":[{"given":"Kaiwen","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishi","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengquan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.142275_bb0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review","volume":"23","author":"Cariou","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0025","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"NAFLD nomenclature consensus group, a multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"2020","key":"10.1016\/j.ijbiomac.2025.142275_bb0035","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"The state of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0050","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0065","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular Cancer in nonalcoholic fatty liver Disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","article-title":"Uric acid in metabolic syndrome: does uric acid have a definitive role?","volume":"103","author":"Copur","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0075","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12072-015-9682-5","article-title":"Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/03009741003742797","article-title":"Gout and risk of non-alcoholic fatty liver disease","volume":"39","author":"Kuo","year":"2010","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0085","doi-asserted-by":"crossref","first-page":"1357664","DOI":"10.3389\/fendo.2024.1357664","article-title":"Non-alcoholic fatty liver disease and coexisting depression, anxiety and\/or stress in adults: a systematic review and meta-analysis","volume":"15","author":"Shea","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0090","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease: current status and future perspective","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0095","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000323","article-title":"Diagnostic performance of FibroTouch ultrasound attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver Disease","volume":"12","author":"Qu","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0105","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","article-title":"Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"29","author":"Gu","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0110","first-page":"362","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study, lancet","volume":"5","author":"Newsome","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.cgh.2023.08.004","article-title":"Point-of-care noninvasive prediction of liver-related events in patients with nonalcoholic fatty liver Disease","volume":"22","author":"Pons","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/pr.112.006833","article-title":"Nuclear receptors and their selective pharmacologic modulators","volume":"65","author":"Burris","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","article-title":"Principles for modulation of the nuclear receptor superfamily","volume":"3","author":"Gronemeyer","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0130","doi-asserted-by":"crossref","first-page":"1386102","DOI":"10.3389\/fcell.2024.1386102","article-title":"Liver X receptors (LXRs) in cancer-an Eagle\u2019s view on molecular insights and therapeutic opportunities","volume":"12","author":"Ramalingam","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0140","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1074\/jbc.M109.006742","article-title":"Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver","volume":"284","author":"Kim","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0145","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.0830671100","article-title":"Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue","volume":"100","author":"Laffitte","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0150","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.M804808200","article-title":"Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0155","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/db11-1255","article-title":"Liver X receptor \u03b1 is involved in the transcriptional regulation of the 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase gene","volume":"61","author":"Zhao","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0160","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3390\/ijms20133241","article-title":"Phytosterols inhibit side-chain oxysterol mediated activation of LXR in breast Cancer cells","volume":"20","author":"Hutchinson","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mam.2016.04.001","article-title":"Once and for all, LXR\u03b1 and LXR\u03b2 are gatekeepers of the endocrine system","volume":"49","author":"Maqdasy","year":"2016","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.plefa.2005.04.009","article-title":"LXR is crucial in lipid metabolism","volume":"73","author":"Ulven","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1755-5922.2008.00062.x","article-title":"Liver X receptors (LXR) as therapeutic targets in dyslipidemia","volume":"26","author":"Be\u0142towski","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nsmb.2778","article-title":"Structure of the retinoid X receptor \u03b1-liver X receptor \u03b2 (RXR\u03b1-LXR\u03b2) heterodimer on DNA","volume":"21","author":"Lou","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0185","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M111041200","article-title":"Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors","volume":"277","author":"Joseph","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0190","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1016\/j.bmcl.2015.07.047","article-title":"Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists","volume":"25","author":"Matsui","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0195","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2174\/1389557054553767","article-title":"The pharmacology of LXR","volume":"5","author":"Michael","year":"2005","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0200","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.bbadis.2011.02.004","article-title":"Liver X receptors, lipids and their reproductive secrets in the male","volume":"1812","author":"Fz","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0205","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/157489006775244245","article-title":"Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis","volume":"1","author":"Bennett","year":"2006","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0215","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1096\/fj.14-254656","article-title":"A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation","volume":"29","author":"Hijmans","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0220","doi-asserted-by":"crossref","first-page":"1102469","DOI":"10.3389\/fmed.2023.1102469","article-title":"Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases","volume":"10","author":"Griffett","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112793","article-title":"Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors","volume":"206","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","article-title":"The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis","volume":"4","author":"Griffett","year":"2015","journal-title":"Mol Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0235","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1021\/acschembio.2c00057","article-title":"Antihyperlipidemic activity of gut-restricted LXR inverse agonists","volume":"17","author":"Griffett","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0240","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0245","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.apsb.2023.08.032","article-title":"Identification of a natural PLA2 inhibitor from the marine fungus aspergillus sp. c1 for MAFLD treatment that suppressed lipotoxicity by inhibiting the IRE-1\u03b1\/XBP-1s axis and JNK signaling","volume":"14","author":"Rao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0260","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0265","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-031-63657-8_12","article-title":"Microbiota and lipotoxicity","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0270","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Cl","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0275","article-title":"Gut microbiota: target for modulation of gut-liver-adipose tissue Axis in ethanol-induced liver Disease","volume":"4230599","author":"Patel","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0280","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s42255-022-00679-6","article-title":"Intestinal plasticity and metabolism as regulators of organismal energy homeostasis","volume":"4","author":"Stojanovi\u0107","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0285","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0290","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0295","first-page":"1496","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease, united European","volume":"6","author":"Rau","year":"2018","journal-title":"Gastroenterol. J."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","article-title":"Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity","volume":"20","author":"Kim","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0305","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0310","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0320","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0325","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0330","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0335","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0340","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0345","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0350","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0355","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver Disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0360","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5604\/01.3001.0010.3829","article-title":"Adipose tissue - morphological and biochemical characteristic of different depots","volume":"71","author":"Murawska-Cia\u0142owicz","year":"2017","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060237","article-title":"It\u2019s not how fat you are, it\u2019s what you do with it that counts","volume":"6","author":"Virtue","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0370","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db16-0213","article-title":"Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD","volume":"65","author":"Softic","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0375","first-page":"708","article-title":"Adiponectin as a novel biomarker for liver fibrosis, world","volume":"10","author":"Udomsinprasert","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0380","doi-asserted-by":"crossref","first-page":"1125395","DOI":"10.3389\/fimmu.2023.1125395","article-title":"Adipose tissue aging is regulated by an altered immune system","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0385","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144801","article-title":"Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2","volume":"131","author":"Liu","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0390","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MOL.0b013e3283508c21","article-title":"Biliary and nonbiliary contributions to reverse cholesterol transport","volume":"23","author":"Temel","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0395","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.febslet.2010.07.035","article-title":"Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice","volume":"584","author":"Jakulj","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0400","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.M400400-JLR200","article-title":"Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1","volume":"46","author":"van der Veen","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0405","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1194\/jlr.M500232-JLR200","article-title":"Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2","volume":"46","author":"Temel","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0410","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-physiol-012110-142233","article-title":"Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport","volume":"73","author":"Jia","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0415","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1752-8062.2009.00098.x","article-title":"Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol","volume":"2","author":"Briand","year":"2009","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1194\/jlr.M054544","article-title":"Relative roles of ABCG5\/ABCG8 in liver and intestine","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0425","first-page":"547","article-title":"Effects of mulberry leaf on experimental hyperlipidemia rats induced by high-fat diet","volume":"16","author":"Huang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0430","first-page":"5936","article-title":"Biliary cholesterol secretion: more than a simple ABC","volume":"16","author":"Dikkers","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0435","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/187152209788009797","article-title":"Opposing gatekeepers of apical sterol transport: Niemann-pick C1-like 1 (NPC1L1) and ATP-binding cassette transporters G5 and G8 (ABCG5\/ABCG8)","volume":"9","author":"Brown","year":"2009","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0440","doi-asserted-by":"crossref","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","article-title":"Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol","volume":"284","author":"van der Veen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0445","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tox.2018.08.007","article-title":"Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease","volume":"410","author":"Li","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0450","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11010-020-03826-3","article-title":"NPC1L1 and ABCG5\/8 induction explain synergistic fecal cholesterol excretion in Ob\/Ob mice co-treated with PPAR-\u03b1 and LXR agonists","volume":"473","author":"Srivastava","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0455","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3904\/kjim.2017.100","article-title":"Duodenal Niemann-pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease","volume":"34","author":"Ahn","year":"2019","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0460","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10620-014-3289-x","article-title":"Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Ahn","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0465","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","article-title":"Gut microbiome lipid metabolism and its impact on host physiology","volume":"31","author":"Brown","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27819","article-title":"Comprehensive bibliometric and visualized analysis of research on gut-liver axis published from 1998 to 2022","volume":"10","author":"Wen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0475","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0480","first-page":"3164","article-title":"High-fat","volume":"10","author":"Malesza","year":"2021","journal-title":"Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review, Cells"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0485","volume":"11","author":"Fei","year":"2020","journal-title":"Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease, mBio."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0490","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0495","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"Schwabe","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0500","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jpedsurg.2017.03.026","article-title":"Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis","volume":"52","author":"Barron","year":"2017","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0505","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/iai.60.2.596-601.1992","article-title":"In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins","volume":"60","author":"Emancipator","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0510","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1074\/jbc.M112.442699","article-title":"High density lipoprotein protects against polymicrobe-induced sepsis in mice","volume":"288","author":"Guo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0515","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1753425912442431","article-title":"Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes","volume":"18","author":"Shao","year":"2012","journal-title":"Innate Immun."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0520","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.RES.0000244014.19589.8e","article-title":"Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels","volume":"99","author":"Brunham","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0525","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","article-title":"Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis","volume":"12","author":"Lo Sasso","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0530","doi-asserted-by":"crossref","first-page":"eabe6729","DOI":"10.1126\/science.abe6729","article-title":"Enterically derived high-density lipoprotein restrains liver injury through the portal vein","volume":"373","author":"Han","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116519","article-title":"The effects of Atractylodes macrocephala extract BZEP self-microemulsion based on gut-liver axis HDL\/LPS signaling pathway to ameliorate metabolic dysfunction-associated fatty liver disease in rats","volume":"175","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0540","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/medicina58050641","article-title":"Chronic inflammation-a link between nonalcoholic fatty liver Disease (NAFLD) and dysfunctional adipose tissue","volume":"58","author":"Petrescu","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0545","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/febs.15877","article-title":"Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease","volume":"289","author":"Thibaut","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154410","article-title":"Role of targeting TLR4 signaling axis in liver-related diseases","volume":"244","author":"Tang","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166480","article-title":"Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response","volume":"1868","author":"Yang","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0560","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1665-2681(19)31247-5","article-title":"Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease","volume":"13","author":"Wenfeng","year":"2014","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0565","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1194\/jlr.M006486","article-title":"Macrophage ABCA1 reduces MyD88-dependent toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol","volume":"51","author":"Zhu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0570","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08009","article-title":"LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling","volume":"4","author":"Ito","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0575","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/pr.2014.157","article-title":"Gut microbiome and nonalcoholic fatty liver diseases","volume":"77","author":"Zhu","year":"2015","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0580","article-title":"Reprogramming of the LXR\u03b1 transcriptome sustains macrophage secondary inflammatory responses","volume":"11","author":"Vladimir de la Rosa","year":"2024","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0585","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/BJ20101701","article-title":"Novel cross-talk within the IKK family controls innate immunity","volume":"434","author":"Clark","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0590","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.celrep.2018.11.100","article-title":"LXR suppresses inflammatory gene expression and neutrophil migration through cis-repression and cholesterol efflux","volume":"25","author":"Thomas","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0595","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2009.01.069","article-title":"Contribution of globular death domains and unstructured linkers to MyD88.IRAK-4 heterodimer formation: an explanation for the antagonistic activity of MyD88s","volume":"380","author":"Mendoza-Barber\u00e1","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003855","article-title":"Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing","volume":"9","author":"De Arras","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0605","article-title":"LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0610","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1074\/jbc.M112.407205","article-title":"An evolutionarily conserved innate immunity protein interaction network","volume":"288","author":"De Arras","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108187","article-title":"Omentin-1 attenuates lipopolysaccharide (LPS)-induced U937 macrophages activation by inhibiting the TLR4\/MyD88\/NF-\u03baB signaling","volume":"679","author":"Wang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0620","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/ijmm.2024.5356","article-title":"Research progress, challenges and perspectives of phospholipids metabolism in the LXR-LPCAT3 signaling pathway and its relation to NAFLD (review)","volume":"53","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0625","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3390\/ijms20153787","article-title":"Revisiting the role of LXRs in PUFA metabolism and phospholipid homeostasis","volume":"20","author":"Jalil","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0630","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M111041200","article-title":"Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors","volume":"277","author":"Joseph","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0635","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","article-title":"Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha","volume":"93","author":"Peet","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0640","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1194\/jlr.M300203-JLR200","article-title":"Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice","volume":"44","author":"Maxwell","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0645","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fphys.2017.00280","article-title":"Role of intestinal LXR\u03b1 in regulating post-prandial lipid excursion and diet-induced hypercholesterolemia and hepatic lipid accumulation","volume":"8","author":"Ben\u00edtez-Santana","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0650","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0655","first-page":"940","article-title":"Effect of Dangfei Liganning capsule on liver X receptor \u03b1\/steroid regulatory element binding protein-1\/fatty acid synthase signal pathway in rats with metabolic- associated fatty liver disease","volume":"42","author":"Xiaoling","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0660","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI99009","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"128","author":"Softic","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0665","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/1873-3468.14818","article-title":"Lipid sensing nuclear receptors involved in the pathogenesis of fatty liver disease","volume":"598","author":"Schweiger","year":"2024","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0670","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature18628","article-title":"TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis","volume":"535","author":"Hsieh","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0675","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","article-title":"El-Gendy bel-D, et al., broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis","volume":"28","author":"Flaveny","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0680","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cb300541g","article-title":"El-Gendy bel-D, et al., a liver-selective LXR inverse agonist that suppresses hepatic steatosis","volume":"8","author":"Griffett","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0685","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","article-title":"The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis","volume":"4","author":"Griffett","year":"2015","journal-title":"Mol Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0690","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0695","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/ATVBAHA.111.225383","article-title":"Peroxisome proliferator-activated receptor-\u03b1 activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway","volume":"31","author":"Nakaya","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.637778","article-title":"Lysosome-dependent LXR and PPAR\u03b4 activation upon Efferocytosis in human macrophages","volume":"12","author":"Mota","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0705","first-page":"900","article-title":"Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice","volume":"51","author":"Bischoff","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0710","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI59817","article-title":"Liver LXR\u03b1 expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice","volume":"122","author":"Zhang","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0715","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/15384101.2022.2042777","article-title":"Molecular mechanisms for ABCA1-mediated cholesterol efflux","volume":"21","author":"Chen","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0720","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/ijms19041260","article-title":"The role of PPAR and its cross-talk with CAR and LXR in obesity and atherosclerosis","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0725","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0730","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1007\/s00018-016-2222-1","article-title":"Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease","volume":"73","author":"Lefere","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046562","article-title":"Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1\u03b1","volume":"7","author":"Shin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0740","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1165\/rcmb.2020-0492OC","article-title":"Hepatocyte HIF-1 and intermittent hypoxia independently impact liver fibrosis in murine nonalcoholic fatty liver Disease","volume":"65","author":"Mesarwi","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0745","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.3390\/nu15245034","article-title":"Cholesterol exacerbates the pathophysiology of non-alcoholic steatohepatitis by upregulating hypoxia-inducible factor 1 and modulating microcirculatory dysfunction","volume":"15","author":"Pereira","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0750","doi-asserted-by":"crossref","first-page":"13299","DOI":"10.3390\/ijms222413299","article-title":"Transcription factor ChREBP mediates high glucose-evoked increase in HIF-1\u03b1 content in epithelial cells of renal proximal tubules","volume":"22","author":"Owczarek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0755","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in Ob\/Ob mice","volume":"55","author":"Dentin","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0760","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI41636","article-title":"The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans","volume":"122","author":"Benhamed","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0765","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/cells9051214","article-title":"LXR\u03b1 regulates ChREBP\u03b1 Transactivity in a target gene-specific manner through an agonist-modulated LBD-LID interaction","volume":"9","author":"Fan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0770","first-page":"61","article-title":"Gr\u00f8nning-Wang, Christian Bindesb\u00f8ll and Hilde I, the role of liver X receptor in hepatic de novo lipogenesis and cross-talk with insulin and glucose signaling, lipid","volume":"1","author":"Line","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0775","doi-asserted-by":"crossref","first-page":"36746","DOI":"10.1038\/srep36746","article-title":"High glucose upregulates BACE1-mediated A\u03b2 production through ROS-dependent HIF-1\u03b1 and LXR\u03b1\/ABCA1-regulated lipid raft reorganization in SK-N-MC cells","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0780","first-page":"686","article-title":"Lipophagy: molecular mechanisms and implications in metabolic disorders","volume":"43","author":"Shin","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0785","first-page":"505","article-title":"PAT protein mRNA expression in primary rat hepatocytes: effects of exposure to fatty acids","volume":"25","author":"Grasselli","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0790","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ncb3166","article-title":"Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis","volume":"17","author":"Kaushik","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0795","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1194\/jlr.M800614-JLR200","article-title":"Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity","volume":"50","author":"Sapiro","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0800","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/15548627.2015.1124226","article-title":"AMPK-dependent phosphorylation of lipid droplet protein PLIN2 triggers its degradation by CMA","volume":"12","author":"Kaushik","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0805","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/15548627.2020.1728097","article-title":"Lipophagy-derived fatty acids undergo extracellular efflux via lysosomal exocytosis","volume":"17","author":"Cui","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0810","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0815","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.3390\/ijms23169196","article-title":"mTOR: a potential new target in nonalcoholic fatty liver Disease","volume":"23","author":"Feng","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0820","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M506850200","article-title":"Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485\/491","volume":"281","author":"Horman","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101635","article-title":"Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy","volume":"36","author":"Gao","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2017.03.026","article-title":"ATGL promotes autophagy\/Lipophagy via SIRT1 to control hepatic lipid droplet catabolism","volume":"19","author":"Sathyanarayan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0835","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2009.12.006","article-title":"Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation","volume":"62","author":"Yu","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0840","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0845","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0850","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41374-021-00715-1","article-title":"IRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPK\u03b1-mTORC1 pathway","volume":"102","author":"Bian","year":"2022","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0855","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13105-020-00737-1","article-title":"Liver X receptor activation induces podocyte injury via inhibiting autophagic activity","volume":"76","author":"Zhang","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108794","article-title":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","volume":"311","author":"Han","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0865","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1042\/BST20221066","article-title":"Insulin signalling and GLUT4 trafficking in insulin resistance","volume":"51","author":"van Gerwen","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0870","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nature13198","article-title":"Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity","volume":"508","author":"Kraus","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0875","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature05449","article-title":"The nuclear receptor LXR is a glucose sensor","volume":"445","author":"Mitro","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0880","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.0830671100","article-title":"Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue","volume":"100","author":"Laffitte","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0885","doi-asserted-by":"crossref","first-page":"48283","DOI":"10.1074\/jbc.M302287200","article-title":"Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha","volume":"278","author":"Dalen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0890","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jiph.2019.09.008","article-title":"Role of LXR alpha in regulating expression of glucose transporter 4 in adipocytes - investigation on improvement of health of diabetic patients","volume":"13","author":"Balasubramanian","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0895","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1194\/jlr.M033977","article-title":"LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in Ob\/Ob female mice","volume":"54","author":"Archer","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0900","doi-asserted-by":"crossref","unstructured":"Ide T, Shimano H, Yoshikawa T, et al., Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling, Mol Endocrinol. 17 (2003) 1255\u20131267.","DOI":"10.1210\/me.2002-0191"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0905","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/JME-16-0196","article-title":"Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet","volume":"58","author":"Dong","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0910","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1038\/s41598-019-45803-x","article-title":"Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR","volume":"9","author":"Zwarts","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0920","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"Controlled trial of the Pan-PPAR agonist Lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0925","first-page":"1080","article-title":"Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial, lancet","volume":"8","author":"Harrison","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0930","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2023.05.013","article-title":"A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease","volume":"79","author":"Romero-G\u00f3mez","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0935","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/dc19-1892","article-title":"Effects of novel dual GIP and GLP-1 receptor agonist Tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes","volume":"43","author":"Hartman","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0940","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0945","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/ijms22062991","article-title":"Plant-based bioactive molecules in improving health and preventing lifestyle diseases","volume":"22","author":"Acquaviva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0950","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1021\/acsnano.1c02158","article-title":"Design of Hepatic Targeted Drug Delivery Systems for natural products: insights into nomenclature revision of nonalcoholic fatty liver Disease","volume":"15","author":"Tang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105540","article-title":"Synthesis and structure activity relationship of the first class of LXR inverse agonists","volume":"119","author":"Elgendy","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0960","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1021\/acschembio.2c00057","article-title":"Antihyperlipidemic activity of gut-restricted LXR inverse agonists","volume":"17","author":"Griffett","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0965","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216845","article-title":"Inhibition of DHCR24 activates LXR\u03b1 to ameliorate hepatic steatosis and inflammation","volume":"15","author":"Zhou","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0970","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.881078","article-title":"Isochlorogenic acid C alleviates high-fat diet-induced Hyperlipemia by promoting cholesterol reverse transport","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0975","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1039\/D3FO01390A","article-title":"The potential role of alfalfa polysaccharides and their sulphated derivatives in the alleviation of obesity","volume":"14","author":"Li","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155145","article-title":"Sesamol as a potential candidate for the treatment of hepatic fibrosis, based on its regulation of FXR\/LXR axis-mediated inhibition of autophagy through crosstalk between hepatic cells and macrophage","volume":"123","author":"Jiang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0985","article-title":"Sesamin, a naturally occurring Lignan, inhibits ligand-induced lipogenesis through interaction with liver X receptor alpha (LXR\u03b1) and Pregnane X receptor (PXR)","volume":"9401648","author":"Tai","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0990","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.690736","article-title":"Kaempferol alleviates steatosis and inflammation during early non-alcoholic steatohepatitis associated with liver X receptor \u03b1-Lysophosphatidylcholine acyltransferase 3 signaling pathway","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb0995","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13034","article-title":"Kaempferol reduces hepatic triglyceride accumulation by inhibiting Akt","volume":"43","author":"Hoang","year":"2019","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1000","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/13880209.2020.1798471","article-title":"Ganoderma lucidum spore ethanol extract attenuates atherosclerosis by regulating lipid metabolism via upregulation of liver X receptor alpha","volume":"58","author":"Lai","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1005","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1021\/acs.jafc.1c02532","article-title":"Apple polyphenol extract improves high-fat diet-induced hepatic steatosis by regulating bile acid synthesis and gut microbiota in C57BL\/6 male mice","volume":"69","author":"Li","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1010","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1039\/D3FO05521C","article-title":"A comparative study of the hypolipidemic effects and mechanisms of action of Laminaria japonica- and Ascophyllum nodosum-derived fucoidans in apolipoprotein E-deficient mice","volume":"15","author":"Liu","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1159\/000508511","article-title":"Molecular study on the potential protective effects of bee venom against fructose-induced nonalcoholic steatohepatitis in rats","volume":"105","author":"Abd El-Haleim","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1020","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/ptr.6747","article-title":"Sophoricoside is a selective LXR\u03b2 antagonist with potent therapeutic effects on hepatic steatosis of mice","volume":"34","author":"Zhang","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5483\/BMBRep.2021.54.2.111","article-title":"Hemistepsin a inhibits T0901317-induced lipogenesis in the liver","volume":"54","author":"Kim","year":"2021","journal-title":"BMB Rep."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108794","article-title":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","volume":"311","author":"Han","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jgr.2023.10.001","article-title":"Ginsenoside F2 restrains hepatic steatosis and inflammation by altering the binding affinity of liver X receptor Coregulators","volume":"48","author":"Kim","year":"2024","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101425","article-title":"Sodium salicylate rewires hepatic metabolic pathways in obesity and attenuates IL-1\u03b2 secretion from adipose tissue: the implications for obesity-impaired reverse cholesterol transport","volume":"56","author":"Kajani","year":"2022","journal-title":"Mol Metab."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1045","doi-asserted-by":"crossref","first-page":"1135952","DOI":"10.3389\/fphar.2023.1135952","article-title":"The ameliorating effect of withaferin a on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR\/FXR dual receptor activator","volume":"14","author":"Shiragannavar","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1050","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.biopha.2018.07.100","article-title":"Effects of lycopene on metabolism of glycolipid in type 2 diabetic rats","volume":"109","author":"Yin","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1055","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1039\/D1FO01039E","article-title":"Lycopene modulates lipid metabolism in rats and their offspring under a high-fat diet","volume":"12","author":"Cao","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1060","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1021\/acs.jafc.0c05077","article-title":"Lycopene prevents DEHP-induced liver lipid metabolism disorder by inhibiting the HIF-1\u03b1-induced PPAR\u03b1\/PPAR\u03b3\/FXR\/LXR system","volume":"68","author":"Zhao","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2019.108929","article-title":"Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice","volume":"130","author":"Zhang","year":"2020","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2024.10.018","article-title":"Thyroid hormone receptor-\u03b2 analogues for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"82","author":"Ratziu","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1075","first-page":"4057","article-title":"Back to roots: Dysbiosis, obesity, metabolic syndrome, type 2 diabetes mellitus, and obstructive sleep apnea-is there an objective connection?","volume":"16","author":"Protasiewicz-Timofticiuc","year":"2024","journal-title":"A Narrative Review, Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.142275_bb1080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","article-title":"The challenges and promise of targeting the liver X receptors for treatment of inflammatory disease","volume":"181","author":"Fessler","year":"2018","journal-title":"Pharmacol. Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025028272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025028272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:46:17Z","timestamp":1782877577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025028272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":216,"alternative-id":["S0141813025028272"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142275","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of liver x receptor alpha in intestine, liver and adipose tissues in metabolic associated fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142275"}}